Weight Loss & Metabolic Health
How Do GLP-1 Medications Work?
Last reviewed: May 2026 · Haute MD Editorial Team
GLP-1 medications are synthetic versions of glucagon-like peptide-1, a hormone the gut releases after eating. They work by binding GLP-1 receptors in the pancreas, brain, and gastrointestinal tract — boosting insulin release in response to meals, suppressing glucagon and hepatic glucose production, slowing gastric emptying, and reducing appetite and food reward signaling. The combined effect lowers blood sugar and produces meaningful weight loss as a downstream effect on energy intake.
The four mechanisms working together
First, in the pancreas, GLP-1 agonists boost glucose-dependent insulin secretion (so they rarely cause hypoglycemia on their own) and suppress glucagon, which lowers liver glucose output. Second, in the stomach, they slow gastric emptying — food stays longer, producing prolonged fullness. Third, in the brain (particularly the hypothalamus and reward centers), they reduce appetite, food cravings, and the rewarding pull of palatable foods. Fourth, in the gut, they may shift the microbiome and improve gut barrier function. These mechanisms together drive both glycemic and weight benefits.
Why GLP-1 medications produce sustained weight loss
Traditional dieting fails because the body defends a higher weight 'set point' — after weight loss, hunger hormones rise, satiety hormones fall, and resting metabolic rate drops. GLP-1 medications directly counteract several of these defense mechanisms by mimicking the natural satiety signal. The result is dramatic appetite reduction without the willpower fatigue typical of dieting, and weight loss that continues over 12-18 months rather than plateauing in weeks.
The class today: GLP-1 and dual agonists
Currently approved single GLP-1 agonists include semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Saxenda, Victoza), dulaglutide (Trulicity), exenatide (Byetta, Bydureon), and lixisenatide. Tirzepatide (Mounjaro, Zepbound) is a dual GLP-1/GIP receptor agonist with greater efficacy. Retatrutide (a triple GLP-1/GIP/glucagon agonist in late-stage development) and oral semaglutide formulations are next on the horizon, and several once-monthly injectables are in trials.
Frequently Asked Questions
Why do GLP-1 medications cause nausea?
Slowed gastric emptying and central effects on the chemoreceptor trigger zone in the brain cause nausea, especially during dose escalation. Slow titration, smaller meals, and avoiding fatty foods help; most patients tolerate fully after 1-3 months.
Do GLP-1 medications affect the brain?
Yes — GLP-1 receptors are present in the hypothalamus, brainstem, and reward centers. This is part of why patients report reduced 'food noise' (background thoughts about food) and decreased cravings for alcohol, ultra-processed foods, and other addictive substances.
Are GLP-1 medications safe?
Yes, with appropriate prescribing. The class has been studied for over 15 years. Most side effects are gastrointestinal and dose-related. Rare but serious risks include pancreatitis, gallbladder disease, and the boxed warning for thyroid C-cell tumors. They are contraindicated in personal or family history of medullary thyroid cancer or MEN2.
Do GLP-1 medications burn fat directly?
Not directly. They produce weight loss by reducing food intake. Without resistance training and adequate protein, up to 25-40% of weight lost can be lean mass — which is why physician supervision and a structured program matter.
Get Help Now
Speak with a Haute MD Internal Medicine physician
Dr. Alexander Golberg
Internal Medicine · New York, NY
View Profile
Dr. Kern Brar
MD
Internal Medicine · Oceanside, CA
View ProfileAre you a Internal Medicine physician?
Join Haute MD Network and have your profile featured alongside these answers.
Apply for the NetworkRelated Guides
Guide · WEIGHT LOSS & METABOLIC HEALTH
What Is Ozempic?
Ozempic is the brand name for semaglutide, a once-weekly GLP-1 injection FDA-approved for type 2 diabetes. It's widely used off-label for weight loss; the on-label weight loss version is Wegovy.
Read GuideGuide · WEIGHT LOSS & METABOLIC HEALTH
Who Is a Candidate for GLP-1 Therapy?
GLP-1 medications are FDA-approved for type 2 diabetes, chronic weight management (BMI ≥30, or ≥27 with comorbidity), and obstructive sleep apnea. Learn who qualifies and what to expect.
Read GuideGuide · WEIGHT LOSS & METABOLIC HEALTH
What Are the Side Effects of GLP-1 Medications?
The most common GLP-1 side effects are nausea, vomiting, diarrhea, and constipation. Less common but serious risks include pancreatitis, gallbladder disease, muscle loss, and thyroid warnings.
Read Guide